Authors: Olsen, E Duvic, M Frankel, A Kim, Y Martin, A Vonderheid, E Jegasothy, B Wood, G Gordon, M Heald, P Oseroff, A Pinter-Brown, L Bowen, G Kuzel, T Fivenson, D Foss, F Glode, M Molina, A Knobler, E Stewart, S Cooper, K Stevens, S Craig, F Reuben, J Bacha, P Nichols, J

Citation: E. Olsen et al., Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T-cell lymphoma, J CL ONCOL, 19(2), 2001, pp. 376-388